Myricanol 1, a constituent of Myrica species, has been reported to lower the levels of the microtubuleassociated protein tau (MAPT), whose accumulation plays an important role in some neurodegenerative diseases, such as Alzheimer’s disease (AD). Herein we described a new synthetic route to prepare myricanol in 9 steps and 4.9% overall yield starting from commercially available 2,3-dimethoxyphenol and methyl 3-(4-benzyloxyphenyl)propanoate. The key steps are a cross-metathesis to obtain a linear diarylheptanoid intermediate and a Suzuki–Miyaura domino reaction to generate the challenging macrocycle.
Convergent total synthesis of (±) myricanol, a cyclic natural diarylheptanoid
A. BochicchioMembro del Collaboration Group
;L. Chiummiento
Writing – Original Draft Preparation
;P. LupattelliMembro del Collaboration Group
;M. FunicelloMembro del Collaboration Group
;COLOBERT, FRANCOISE
Writing – Original Draft Preparation
2018-01-01
Abstract
Myricanol 1, a constituent of Myrica species, has been reported to lower the levels of the microtubuleassociated protein tau (MAPT), whose accumulation plays an important role in some neurodegenerative diseases, such as Alzheimer’s disease (AD). Herein we described a new synthetic route to prepare myricanol in 9 steps and 4.9% overall yield starting from commercially available 2,3-dimethoxyphenol and methyl 3-(4-benzyloxyphenyl)propanoate. The key steps are a cross-metathesis to obtain a linear diarylheptanoid intermediate and a Suzuki–Miyaura domino reaction to generate the challenging macrocycle.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
2018-OBC_myricanol.pdf
solo utenti autorizzati
Tipologia:
Pdf editoriale
Licenza:
DRM non definito
Dimensione
548.21 kB
Formato
Adobe PDF
|
548.21 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.